Dr. Jason X. Cheng stayed at University of Chicago to get his Hematopathology fellow under the guidance of Dr. James W. Vardiman, one of the top authorities in Diagnostic Hematopathology. He completed his fellowship training in 2010, and then became an assistant Professor in University of Michigan at Ann Arbor where he was the head of Epigenetics Laboratory. Dr. Cheng came back to become a faculty in the Hematopathology Section at University of Chicago in 2013. He has quite a few scientific publications and a patent issued by the U.S. patent agency. He also had multiple awards including Cancer Research Foundation Young Investigator Award, the society for Hematopathology Pathologist-in-Training Award, the Paul E. Strandjord Young Investigator Award from Academy of Clinical Physicians and Scientists, the Robert E. Priest Fellowship, …etc.
Roberto Verna, Roma, 12 Agosto 1947. Professor of Clinical Pathology, Department of Experimental Medicine - Faculty of Medicine, Sapienza University of Rome, Viale Regina Elena, 324 - 00161 Roma, since 1986. President, World Association of Societies of Pathology and Laboratory Medicine; Past President SIPMeL; President, World Pathology Foundation; Member of the ExCo of CIOMS; Member of the Board of FISMeLab; Member of the Board FISM. Degree in Medicine and Surgery; Degree in Biological Sciences; Specialization in Science of Nutrition; General Pathology; Endocrinology, University of Rome, full votes with honors. Appointed of the Chair of Clinical Pathology at the University of L'Aquila then Rome. Visiting Scientist, LMB, NCI. NIH, Bethesda MD; INSERM, Hopital Necker, Paris – France; NIDDKD, NIH, USA. 2004-2011, Director of the Clinical Research Center of the University of Rome 2012- 2017 Director of the Center for Sports Medicine and Management Member of the Board of several Scientific Societies and Organisations. Member of the Commission for the Monitoring and Control of Doping and the Protection of Health in Sporting Activities, Ministry of Health President of the Commission of the Ministry of Health for Soccer synthetic surface Fields Representative of WASPaLM to WHO Member of the Malaysian Academy of Medicine. Member of the Scientific Committee of the Journals: Malaysian Journal of Pathology Human Pathology. Case reports Author of more than 150 publications on the main international Journals. Author of 12 scientific books.
Laboratory of Sports activity; Aging; Dyslipidemias; Endocrinology and Metabolic Diseases; Clinical Value of Laboratory; Molecular Oncology
Dr. Altaf Taher is currently the Divisional Chief of Pathology at Eastern Health in St. John’s, Canada. He is also employed by the Faculty of Medicine at Memorial University of Newfoundland. He serves as the Program Director of the Residency Training Program in Anatomical Pathology. Altaf received his medical degree from JNMC College in Belgaum, India and went on to do his specialization in Pathology from Kasturba Medical College in Mangalore, India in 1990. After practicing pathology for more than a decade he immigrated to Canada where he was recertified by the Royal College of Physicians of Canada in 2008. He subsequently was a fellow in the Gastrointestinal Pathology division at Brigham and Women’s Hospital in Boston from 2009 to 2010. He also received certification from the American Board of Pathology in 2010. He joined Memorial University as an Assistant Professor in 2009. He became the Residency Program Director in 2014. He has proven skills as a leader and became the Divisional Chief of Pathology in 2016. His interests are mainly in education and he teaches both at the undergraduate and post graduate levels. His specialization in Gastrointestinal Pathology has made him one of the few pathologists with a special interest in pancreato-biliary pathology in the entire province of Newfoundland.
Adenocarcinoma of the GE Junction | Dysplasia in Barrett's | Her2 in Gastric Cancer
Kristin is a Managing Director of EY-Parthenon and Global Head of the Life Sciences practice. Based in the Boston office, she has 20 years of experience in the life sciences sector. Kristin is serving clients in the pharmaceutical, biotech, diagnostics and life science tools industries, with a focus on company and investor commercial strategy and M&A support for diagnostics, life science research and pharmaceutical companies. She is also the creator and leader of EY Precision Medicine™. Prior to joining EY in 2013, Kristin was a partner and owner of Health Advances, where she managed the firm with four other partners and developed and led a global Diagnostics and Life Sciences practice focused on product and service strategy, corporate strategy, health economics and deal diligence. She is also a founder of DxInsights, a nonprofit organization designed to educate the nation’s health care communities on the impact of diagnostics in improving health care outcomes. Kristin earned a BA in Biochemistry from Smith College and an MS in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health.
Dr. Siew-Khin Tang, known to her friends and colleagues as "Happy", joined Dorevitch Pathology in July 2006. After 17 years at the Alfred Hospital as a Consultant Anatomical Pathologist and Cytopathologist, with a brief stint in private pathology, she returned in 2004 to the Victorian Cytology Service where she had previously worked closely with Dr. Michael Drake (1962 - 1968, 1973 - 1979), the doyen for the Victorian Cervical Cancer Screening Service in the 1960s. Her return to histopathology at Dorevitch Pathology has been prompted by her strong interest in endoscopic biopsies of the Gastrointestinal tract, breast and gynaecological pathology. She is well known for her experience in the wide field of cytopathology, including Fine Needle Aspiration cytology. She is currently expanding her interest in dermatopathology.
Larry Nichols, M.D., is professor of pathology and interim chair of the department of pathology of the Mercer University School of Medicine. Before that, he was professor of pathology and vice chair for education at the University of Tennessee College of Medicine. Prior to that, he was associate professor of pathology and chief of the multi-hospital autopsy service for the University of Pittsburgh Medical Center. Before that, he was assistant professor of pathology at the University of Southern California and did autopsies of AIDS patients for all of Los Angeles County. He has also done clinical antibiotic research and worked for the British National Health Service. He earned his M.D. from the University of Wisconsin and did residency training in internal medicine and pathology at the Harvard Medical School New England Deaconess Hospital. Over the years, his research interests have shifted from antibiotics to AIDS to cardiac and pulmonary pathology and, most recently, medical education. Since coming to the Mercer University School of Medicine, Dr. Nichols has been publishing case reports based on the thousands of hospital patient autopsies that he has done, often focused on the lessons for patient safety from those cases. He serves as a scientific editor of the Brazilian journal Autopsy and Case Reports published by the medical school of the University of Sao Paolo and as one of the editors of the Archives of Pathology and Laboratory Medicine published by the College of American Pathologists. Dr. Nichols has joined the group of infectious disease physicians at the Navicent Medical Center and he takes a turn every fourth week presenting cases at their infectious diseases case conference. He is working with the chair of the department of surgery at the Navicent Medical Center in a laboratory bench research study of fibrosis from abdominal surgery. Dr. Nichols is collaborating with individuals at the medical school of the Free University of Brussels in Belgium, which hosts his website of virtual slides and associated patient histories, freely accessible for medical education anywhere in the world.
Cardiac and Pulmonary Pathology
Victoria Dowling is a 29 year old General Surgeon and Coloproctologist from University Hospital of Caracas, Venezuela, where she currently works. At present she belongs to a surgery team that has conducted over 500 operations related to the study of EFFICACY IN THE USE OF LOCAL ANESTHESIA IN PATIENTS WITH SURGICAL INTERVENTION FOR THE RESOLUTION OF ANORECTAL PATHOLOGIES.
EFFICACY IN THE USE OF LOCAL ANESTHESIA IN PATIENTS WITH SURGICAL INTERVENTION FOR THE RESOLUTION OF ANORECTAL PATHOLOGIES.
Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Dr. Wassil Nowicky became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids “NSC-631570”. He used the factor that cancer cells are more negative charged than normal cells and invented the Celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmasists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.
Anticancer protonic therapy
Dr Jan Jacques Michiels is a Lifestyle Physician and Medical Doctor, MD, educated in Internal Medicine, Hematology, Bloodcoagulation and Vascular Medicine and graduated as PhD at the Erasmus University Medical Center, Rotterdam based on his Thesis Erythromelalgia & Thrombocythemia in 1981. Dr Michiels published more than 400 original manuscripts in peer reviewed international medical journals . Dr Michiels frequently served as Guest Editor and was the Founder and Editor in Chief of Seminars in Vascular Medicine. Dr Michiels is the Founder of the Thrombocythemia Vera Study Group (TVSG) in 1994, the European Working Group on Myeloproliferative Disorders EWG.MPD in 1998 and Myeloproliferative Neoplasms EWG.MPN in 2006 as scientific working groups of the European Hematology Association: EHA. Dr. JJ Michiels is the founder and chair of International Collaboration and Academic Research on Myeloproliferative Neoplasms: ICAR.MPN in 2015 within the HARMONY project of the EHA to collect big data on MPN to improve health and quality of life of MPN patients. Dr Jan Jacques Michiels is the founder and scientific director of the Goodheart Institute & Foundation in Nature Medicine & Health, Rotterdam, The Netherlands, Freedom of Science and Education, Free University Network: FUN Europe. Dr JJ Michiels is co-founder of the Central European Vascular Forum (CEVF) and allied Thrombosis Hemostasis Research Group. Dr Michiels serves as consultant professor in the Hematology and Bloodcoagulation University Hospital Antwerp with special attention to MPN and was co-founder of the VWF-VWD Research Institute of the Hemostasis Thrombosis Laboratory at the Department of Hematology University Hospital, Antwerp. Dr JJ Michiels serves as consultant professor in Hematology and Bloodcoagulation, Comenius University, Bratislava, Slovakia; consultant to the Dutch Society of Internal Medicine and the Ministery of Health Science and Sport and consultant of quality driven Industrial and Pharmaceutical Medicine. Dr JJ Michiels is a editor in chief of 3 Medical Journals and acts as a Guest Editor on request and by self initiation. Dr Michiels is active member of the Belgian, Dutch, German and International Societies on Thrombosis and Haemostasis (ISTH), the European Hematology Association (EHA) and Honory Member of the American Society of Hematology (ASH).
Thrombosis, Benign Monoclonal Gammapathies
Dimitrios H. Roukos, MD, Ph.D., is Professor of Surgery – Precision Cancer Medicine and Founding director of “Centre for Biosystems and Genome Network Medicine” in the Ioannina University, School of Medicine. His translational and clinical research from traditional and single gene investigation to molecular networks and clinical cancer genome NGS analysis has been recognized by the international scientific community. He has published more than 236 PubMed papers with recent focus on NGS conventional and breakthrough genome analysis (> 80 articles) and more recently in precision cancer medicine (31 articles). These publications have received more than 8420 citations with h-index: 72 (Scopus). He is a reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Belgium, Luxemburg, Poland), and member in the editorial board of 25 international journals with IF. He has been invited as a speaker in many international and world congresses
Molecular interaction networks, Translational Single – Gene Research, Intratumor Heterogeneity (ITH) with multiregional NGS
Hossein Hosseinkhani, Chemical Engineer, has 30 years of experience in biomedical engineering in both academia and industry in biomedical engineering research and development, which includes several years of essential science research experience in a number of premier institutions related to the structure and function of biomaterials, and in polymer-based medical implants development in the medical device industry. He is the inventor of 22 International patents, several of which are licensed to companies acting in the biomedical fields and translated to 7 commercial products. He authored more than 100 scientific papers published in peer-reviewed journals, and 5 books (H-index: 46 Google Scholar). He is the founder of Matrix, Inc. a world-leading biotech company dedicated to healthcare technology to improve patients' quality of life. He is Editor-in-Chief of Recent Progress in Materials, a peer-reviewed Open Access journal published online by LIDSEN Publishing Inc., and Editor-in-Chief of Journal of Modern Nanotechnology, a peer-reviewed Open Access journal published online by the Innovation Forever Publishing Group Limited. Dr. Hosseinkhani also has been selected as the Country Editor of Current Drug Delivery.
Nanotechnology, Biomaterials, Drug discovery, 3D in vitro systems, Bioreactor technology, and Bioengineering stem cells technology
Dr. Luca Roncati, Italian pathologist, academic editor of the European Journal of Gynaecological Oncology, physician-scientist, anti-cancer patent inventor, medical lecturer, and award-winning author with more than 250 publications to his credit, specialized in gynecologic oncology and hematopathology, eponym of Roncati-Manenti triad, describer of T rex lymphoma, pioneering researcher in COVID-19, forensics expert and adjunct professor of anatomical pathology at the University of Modena and Reggio Emilia (Italy).
Surgical pathology; Oncology; Gynecologic pathology; Gynecologic oncology; Breast cancer; Hematopathology; Oncohematology; Lymphoma; Epstein-Barr virus (EBV); Kaposi's sarcoma-associated herpesvirus (HHV8); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Human papilloma virus (HPV); HPV test; PAP smear; Anatomical pathology; Forensic sciences.